Author Question: Sociologist Peter Bearman has studied the impact of virginity pledges and his findings show that ... (Read 158 times)

Tirant22

  • Hero Member
  • *****
  • Posts: 532
Sociologist Peter Bearman has studied the impact of virginity pledges and his findings show that among those teenagers who take this pledge the following has occurred:
 
  a. the pledges reduced the teenage sexual intercourse
  b. the pledges are most effective among older teens
  c. the pledges have proven to be a source of frustration for parents
  d. the teens' social networks are not supportive

Question 2

In a study of a Midwestern metal-products factory, Michael Burawoy found that when changes based on the human-relations approach were introduced:
 
  a. worker-management conflict increased
  b. worker productivity increased
  c. workers became more alienated
  d. workers continued to limit their output



Sarahjh

  • Sr. Member
  • ****
  • Posts: 370
Answer to Question 1

A

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Vaccines cause herd immunity. If the majority of people in a community have been vaccinated against a disease, an unvaccinated person is less likely to get the disease since others are less likely to become sick from it and spread the disease.

Did you know?

The cure for trichomoniasis is easy as long as the patient does not drink alcoholic beverages for 24 hours. Just a single dose of medication is needed to rid the body of the disease. However, without proper precautions, an individual may contract the disease repeatedly. In fact, most people develop trichomoniasis again within three months of their last treatment.

Did you know?

Approximately one in four people diagnosed with diabetes will develop foot problems. Of these, about one-third will require lower extremity amputation.

Did you know?

Medication errors are more common among seriously ill patients than with those with minor conditions.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library